# Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

> **NCT07397442** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Beijing Friendship Hospital** · enrollment: 19 (estimated)

## Conditions studied

- Rectal Cancer, Adenocarcinoma
- Rectal Cancer Stage II
- Rectal Cancer Stage III

## Interventions

- **COMBINATION_PRODUCT:** Short-Course Radiotherapy Combined with Chemotherapy and Immunotherapy

## Key facts

- **NCT ID:** NCT07397442
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2033-02-28
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07397442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07397442, "Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07397442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*